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L. INGEBORGH VAN DEN BORN, AND CAROLINE C.W. KLAVER PURPOSE: It is unknown which retinal cells are
involved in the retina-to-sclera signaling cascade causing
myopia. As inherited retinal dystrophies (IRD) are char-
acterized by dysfunction of a single retinal cell type and
have a high risk of refractive errors, a study investigating
the affected cell type, causal gene, and refractive error in
IRDs may provide insight herein.
 DESIGN: Case-control study.
 METHODS: STUDY POPULATION: Total of 302 patients
with IRD from 2 ophthalmogenetic centers in the
Netherlands. REFERENCE POPULATION: Population-based
Rotterdam Study-III and Erasmus Rucphen Family Study
(N [ 5550). Distributions and mean spherical equiva-
lent (SE) were calculated for main affected cell type and
causal gene; and risks of myopia and hyperopia were eval-
uated using logistic regression.
 RESULTS: Bipolar cell-related dystrophies were associ-
ated with the highest risk of SE high myopia 239.7;
odds ratio (OR) mild hyperopia 263.2, both P <
.0001; SEL6.86 diopters (D) (standard deviation [SD]
6.38), followed by cone-dominated dystrophies (OR
high myopia 19.5, P < .0001; OR high hyperopia
10.7, P[ .033; SEL3.10 D [SD 4.49]); rod dominated
dystrophies (OR high myopia 10.1, P< .0001; OR high
hyperopia 9.7, P[ .001; SEL2.27 D [SD 4.65]), and
retinal pigment epithelium (RPE)-related dystrophies
(OR low myopia 2.7; P [ .001; OR high hyperopia
5.8; P [ .025; SE L0.10 D [SD 3.09]). Mutations in
RPGR (SE L7.63 D [SD 3.31]) and CACNA1F
(SE L5.33 D [SD 3.10]) coincided with the highestr publication Jul 10, 2017.
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© 2017 ELSEVIER INC. Adegree of myopia and in CABP4 (SE 4.81 D [SD 0.35])
with the highest degree of hyperopia.
 CONCLUSIONS: Refractive errors, in particular
myopia, are common in IRD. The bipolar synapse and
the inner and outer segments of the photoreceptor may
serve as critical sites for myopia development. (Am J
Ophthalmol 2017;182:81–89.  2017 Elsevier Inc. All
rights reserved.)
R
EFRACTIVE ERRORS (MYOPIA AND HYPEROPIA) ARE
the most common ocular disorders worldwide and
are a prominent cause of blindness.1 This highly
heritable trait has been subject to many studies, and the
search for genes—in particular for myopia—has been
ongoing for several years.2,3 Myopia is thought to be
caused by a visually evoked retina-to-sclera-signaling
cascade. Various genes representing different pathways in
myopia development have been discovered.4,5 These
pathways include neurotransmission, retinoic acid
metabolism, extracellular matrix remodeling, and eye
development. Still, only a small proportion of the
heritability of refractive error has been uncovered.5
It is known that refractive errors are common in patients
with inherited retinal dystrophies (IRD), such as retinitis
pigmentosa (RP, in particular in X-linked forms6), congen-
ital stationary night blindness, Stargardt disease, and Best
macular dystrophy.7–9 IRDs are clinically and genetically
heterogeneous, usually causing degeneration of a primary
cell type, such as the retinal pigment epithelium (RPE),
photoreceptors (cones and rods), or other retinal
neurons.10According to the location of retinal cell dysfunc-
tion, they can be classified into RPE-relatedmacular dystro-
phies, photoreceptor dystrophies (cone- and rod-dominated
dystrophies), and inner retina dystrophies (bipolar cell dys-
functions). Stargardt disease, caused by mutations in the
ABCA4 gene, is the most common form of macular dystro-
phy.11,12 Other more rare RPE-related macular dystrophies
are Best macular dystrophy and pattern dystrophy. Cone-
dominated dystrophies include achromatopsia, cone dystro-
phies (CD), and cone-rod dystrophies (CRD).13 Rod-cone
dystrophies (RCD), also known as RP, are the largest sub-
type of IRD, accounting for w50% of all inherited
IRDs.14 Lastly, congenital stationary night blindness
(CSNB) is usually caused by defective retinal signaling
from the photoreceptors to the ‘‘ON’’ bipolar cells.1581LL RIGHTS RESERVED.
IRDs may serve as naturally occurring experiments to
study the specific cell types and structures involved in the
development of myopia. Although several former reports
refer to an increased incidence of myopia in patients with
inherited retinal dystrophies, most do not include specific
quantifiable data, and their spectrum of diseases is
limited.6,7,16
Here, we studied a large group of patients with a broad
spectrum of inherited IRDs. We investigated frequency
and degree of refractive error as a function of affected cell
type and causal gene, with the aim to detect bottlenecks
for myopia development.METHODS
 SUBJECTS: IRD patients were identified at ophthalmoge-
netic outpatient clinics of Erasmus Medical Center (n ¼
265) and the Rotterdam Eye Hospital (n ¼ 37). These 2
ophthalmogenetic centers belong to the Dutch IRD regis-
try, the RD5000 Consortium.17 The total study population
consisted of 302 patients with IRD, and we identified 4
groups of primary affected cell type: RPE-related macular
dystrophies (RPE; Stargardt and Best disease and PD; n ¼
77), cone-dominated dystrophies (CD; achromatopsia,
CRD, n ¼ 76), rod-dominated dystrophies (RD; RP and
RCD; n ¼ 104), and ON bipolar cell dysfunctions
(BPCD; n ¼ 45). To compare the distribution of refractive
error to a general population, we used a population-based
reference group (n ¼ 5550), a combined dataset from
2940 participants (age 45þ years) from the Rotterdam
Study III (RS-III),18 and 2610 participants (age 18þ years)
from the Erasmus Rucphen Family Study (ERF).19,20
Data of IRD patients enrolled in the RD5000 database
were pseudonymized and personal details were only avail-
able at their ophthalmological center, which makes
informed consent not obligatory. Nevertheless, we created
an informed consent to obtain patient approval for data en-
try in the RD5000 database. Measurements in the Rotter-
dam Study and ERF were collected after receiving
approval from the Medical Ethics Committee of the Eras-
mus University Medical Center, and all participants pro-
vided written informed consent in accordance with the
Declaration of Helsinki.
 CLINICAL ASSESSMENT: We retrieved all clinical data
from medical charts. These data included Snellen visual
acuity, cycloplegic objective refraction based on autore-
fraction (retinoscopy was used whenever autorefraction
failed) followed by subjective refraction, color vision
(Hardy-Rand-Rittler color vision test or Ishihara), visual
field tested by Goldmann perimetry, and electroretino-
graphic responses according to ISCEV.21 All ophthalmic
data were reviewed by retinal medical specialists with
expertise in ophthalmic genetics (L.I.v.d.B., C.C.W.K.).82 AMERICAN JOURNAL OFFor RS-III and ERF (reference group) a similar protocol
was used for phenotyping; all subjects underwent an
ophthalmologic examination, which included noncyclo-
plegic automated measurement of refractive error (Topcon
RM-A2000 autorefractor, Tokyo, Japan), followed by sub-
jective refraction, best-corrected visual acuity, fundus
photography, and visual field perimetry (Humphrey Visual
Field Analyzer; Zeiss, Oberkochen, Germany).
 MOLECULAR GENETIC ANALYSIS: In the outpatient
clinic, patients with inherited IRDs were offered DNA
analysis for diagnostic testing. DNA was isolated from pe-
ripheral blood lymphocytes using standard procedures.
ABCA4 gene mutations were analyzed in CD and RD pa-
tients with microarray screening from Asper Biotech
(Tartu, Estonia). Genotyping was performed using the
autosomal recessive and autosomal dominant RP chip
from Asper Biotech (Tartu, Estonia). In patients with RP
and deafness suspected for Usher syndrome an additional
USH chip from Asper Biotech was used. All mutations
were confirmed with Sanger sequencing. When one muta-
tion was found with the autosomal recessive or Usher chip,
the whole gene was sequenced in order to identify a second
mutation, if present. X-linked CRD or X-linked RCD
probands were screened for mutations in the RPGR gene.
Patients clinically diagnosed with CSNB were screened
for mutations in the CACNA1F, TRPM1, CABP4, and
NYX gene.
 STATISTICAL ANALYSIS: Spherical equivalent (SE) was
calculated according to the standard formula (SE ¼
sphere þ ½ cylinder), and the mean of both eyes was
used for analysis. When data from only 1 eye were avail-
able, the SE of this eye was used. We categorized SE into
low (SE from 1.5 to 3 diopters [D]), moderate
(SE from 3 to 6 D), and high (SE of 6 D or lower)
myopia; emmetropia (SE from 1.5 to þ1.5 D); and
low (SE from þ1.5 to þ3 D), moderate (SE from þ3
toþ6 D), and high (SE ofþ6 D or higher) hyperopia, using
previously defined criteria.22
Analyses were stratified by main affected cell type (RPE,
CD, RD, or BPCD) and by causal gene. Causal genes that
were found in fewer than 3 patients were pooled into a sin-
gle group (‘‘other genes’’). Logistic regression analyses were
used to assess the risk of low, moderate, and high myopia
and hyperopia vs emmetropia per disease group, using the
RS-III and ERF study as the reference group, and adjusting
for age and sex. Subgroup analyses (analysis of variance
tests, independent samples t test) were performed to
compare mean SE between different causal genes, between
subgroups and the reference population, between different
ABCA4-related dystrophies (Stargardt, CRD, and RCD),
and between RPE-related dystrophies (Stargardt, Best,
pattern dystrophy). Since age has an influence on SE, we
stratified analysis by age (<25 years; >_25 years) and used
the Student t test to compare the mean SE between theseOCTOBER 2017OPHTHALMOLOGY
TABLE 1. Clinical Characteristics of Our Study Population Stratified by Main Affected Cell Type of Inherited Retinal Dystrophy
RPE (n ¼ 77) CD (n ¼ 76) RD (n ¼ 104) BPCD (n ¼ 45)
RS þ ERF
(n ¼ 5,550)
STGD BEST PD Achromatopsia CRD RCD CSNB Reference
N total 54 18 5 14 62 104 45 5,550
Sex
Male, N (%) 22 (40.7) 9 (50.0) 1 (20.0) 10 (71.4) 40 (64.5) 52 (50) 42 (93.3) 42 (44.0)
Age
Mean age of onset, N (SD) 29.1 (16.9) 26.9 (22.2) 54.2 (10.1) 6.8 (5.75) 18.3 (14.6) 20.3 (17.1) 7.7 (12.7) na
Mean age at SE
measurement, N (SD)
37.6 (16.2) 37.8 (23.8) 57.8 (10.6) 30.3 (17.6) 33.9 (17.3) 37.6 (16.7) 22.5 (15.8) 53.1 (11.6)
Mean SE (SD) 1.1 (2.7) 2.3 (2.9) 1.8 (2.5) 2.9 (5.0) 3.15 (4.1) 2.3 (4.7) 6.9 (6.4) 0.0 (2.3)
DNA sample available, N (%) 51 (94.4) 14 (77.8) 5 (100.0) 13 (92.9) 53 (84.1) 98 (94.2) 18 (40.9) na
At least one mutation, N (%) 35 (64.8) 11 (61.1) 3 (60.0) 11 (78.6) 31 (50.8) 68 (65.4) 13 (29.5) na
Genetically solveda, N (%) 16 (29.6) 11 (61.1) 3 (60.0) 9 (64.3) 20 (33.3) 41 (39.4) 11 (25.0) na
BEST ¼ Best macular dystrophies; BPCD ¼ bipolar cell dysfunctions; CD ¼ cone-dominated dystrophies; CRD ¼ cone-rod dystrophies;
CSNB ¼ congenital stationary night blindness; na ¼ not applicable; PD ¼ pattern dystrophy; RCD ¼ rod-cone dystrophies; RD ¼ rod-
dominated dystrophies; RPE¼ retinal pigment epithelium–related macular dystrophies; SE¼ spherical equivalent; STGD¼ Stargardt disease.
aDefined as the identification of 1 (in autosomal dominant or X-linked disease) or 2 pathogenic mutations (autosomal recessive disease)
FIGURE 1. Frequency of causal genes in the study population
(n[ 172). The group ‘‘other’’ consists of various genes found
in fewer than 3 subjects.
TABLE 2. Distribution of Spherical Equivalent in ‘‘Other
Genes’’
Other Genes N (Total N ¼ 17) SE
ALMS1 1 6.81
BBS5 1 0.06
CERKL 1 0.13
CNGA1 1 2.50
CNGA3 1 8.50
EYS 2 4.75; 0.88
GUCY2D 2 23; 3.50
IMPG2 1 6.38
KCNV2 1 3.25
NYX 1 11.00
PDE6B 1 0.25
PDE6C 1 12.00
PRPF8 1 0.38
TRPM1 1 8.31
SE ¼ spherical equivalent.
‘‘Other genes’’: genes with causal mutations found in fewer
than 3 subjects were pooled.
age groups. All analyses were performed using SPSS version
20 (SPSS Inc, Chicago, Illinois, USA).RESULTS
CLINICAL CHARACTERISTICS OF THE STUDY POPULATION
(n ¼ 302) categorized by diagnosis are summarized in
Table 1. Of all patients with RPE-related macular dystro-
phies (n¼ 77), most were diagnosed with Stargardt disease
(n¼ 54), 18 with Best disease, and only a small group withVOL. 182 BIPOLAR SYNAPSE AND PHOTORECEPTOpattern dystrophy (n ¼ 5). In the group with CD (n ¼ 76),
15 patients had achromatopsia and 61 patients CRD. The
largest group was formed by patients with RD, including
104 RCD patients. With 45 CSNB patients, BPCD formed
the smallest group.
A DNA sample was available in 83% of all included pa-
tients. In 57% of our study population at least 1 mutation
was found. In total, 37% of the cases were genetically
solved (autosomal recessive, autosomal dominant, or83R AS CRITICAL SITES FOR MYOPIA
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FIGURE 2. Refractive error distribution in retinal dystrophies. Percentages of subcategories of mean spherical equivalent are shown
for patients with retinal pigment epithelium (RPE)-related dystrophies (RPE), cone-dominated dystrophies (CD), rod-dominated
dystrophies (RD), and bipolar cell dysfunctions (BPCD), compared to our reference group (RS-III and ERF). Mean standard error
(SE) in diopters (D) ± standard deviation is shown above each subgroup. RS-III[ Rotterdam Study III; ERF[ Erasmus Rucphen
Family Study.X-linked inherited) (Table 1). This was defined as the iden-
tification of 1 (in autosomal dominant or X-linked disease)
or 2 pathogenic mutations (autosomal recessive disease).
Figure 1 shows the frequency of mutations found in various
genes within the subtypes of inherited retinal diseases.
Genes causing the disease in fewer than 3 patients were
pooled. All gene-specific data can be found in Table 2.
The distributions of SE in our patient group and refer-
ence group are shown in Figure 2. In CD (mean
SE 3.10 D [SD 4.49]), RD (mean SE 2.27 D
[SD 4.65]), and BPCD (mean SE 6.86 D [SD 6.38]) the
distribution was skewed toward the left (more myopic)
compared to RPE-related macular dystrophies (mean
SE 0.10 D [SD 3.09]) and the reference group (mean
SE þ0.04 D [SD 2.32]). Figure 3 shows the risks of myopia
and hyperopia per disease group, compared to the reference
population. Persons with ON bipolar cell dysfunctions had
the highest risk of refractive error (odds ratio [OR] high
myopia 239.7 and OR mild hyperopia 263.2, both
P < .0001), followed by cone-dominated dystrophies
(OR high myopia 19.5, P < .0001; and OR high hyperopia
10.7, P ¼ .033), rod-dominated dystrophies (OR high
myopia 10.1, P<0.0001; OR high hyperopia 9.7,
P ¼ 0.001), and RPE-related dystrophies (OR low myopia
2.7; P¼ .001; andOR high hyperopia 5.8; P¼ .025). A sub-
group analysis within the RPE-related macular dystrophies
showed a significant (P < .0001) difference in mean SE
between Stargardt patients (n ¼ 54; mean SE 1.10 D
[SD 2.68]) and Best patients (n ¼ 18; mean SE þ2.34 D
[SD 2.91]).
Table 3 shows the mean SE stratified by age at first visit.
Mean age at first visit in our study population (n¼ 302) was
35 years (SD 18), ranging from 0 to 80 years and differing84 AMERICAN JOURNAL OFbetween subtypes. Only patients with rod-dominated dys-
trophies were significantly (P ¼ .027) more myopic
(mean SE 2.83 D [SD 4.65]) at age >25 years compared
to <_25 years (mean SE 0.49 D [SD 4.22]).
Figure 4 shows the SE distribution for various genes
causing inherited retinal dystrophies, and their location
in the retina. Most genes (9 out of 14) coincided with
myopia. The ABCA4 gene formed the most common
disease-causing gene (n ¼ 62; mean SE 2.02 D [SD
3.71]). Mutations in the ABCA4 did not cause statistically
different degrees of myopia depending on the diagnosis,
that is, Stargardt disease (SE 1.50 [SD 2.85]) and cone-
rod dystrophy (SE 2.72 [SD 4.11]), P ¼ .493. Patients
with mutations in the BEST1 gene (n ¼ 11) had a mean
SE of þ1.84 D [SD 2.95], which is significantly higher
than the mean SE of the ABCA4 (n ¼ 62; P ¼ .051) or
the RPGR gene (n¼ 6; P¼ .001). Patients with mutations
in the RPGR gene (n ¼ 6) were the most myopic (mean
SE 7.63 D [SD 3.31) of all, followed by CACNA1F
(n ¼ 8; mean SE 5.33 D [SD 3.10]). Patients with muta-
tions in the CABP4 gene (n¼ 3) had the highest degree of
hyperopia (mean SE 4.81 D [SD 0.35]).DISCUSSION
WE STUDIED REFRACTIVE ERROR IN 302 PATIENTS WITH IRD
who consecutively entered a national database, and found
that genes involved in these diseases often coincide with
either myopia or hyperopia. Our results show that in partic-
ular BPCD is associated with high myopia and high hyper-
opia, and CD and RP as a groupmostly lead to mild myopia.OCTOBER 2017OPHTHALMOLOGY
FIGURE 3. Risk of myopia and hyperopia per main affected cell type. This plot shows odds ratios of several degrees of myopia (Right)
and hyperopia (Left) vs emmetropia per disease group. The RS-III and ERF study were used as the reference group (R), and analyses
were adjusted for age and sex. The BPCD group was too small to calculate an odds ratio for high hyperopia (na). OR[ odds ratio; RS-
III [ Rotterdam Study III; ERF [ Erasmus Rucphen Family Study; RPE [ retinal pigment epithelium–related macular dystro-
phies; CD [ cone-dominated dystrophies; RD [ rod-dominated dystrophies; BPCD [ bipolar cell dysfunction; na [ not appli-
cable; ns[ nonsignificant.
TABLE 3. Spherical Equivalent Stratified by Age
<10 Years 10-25 Years >25 Years
P TrendN Mean SE (6SD) N Mean SE (6SD) N Mean SE (6SD)
RPE (n ¼ 77) 5 3.9 (2.9) 15 0.86 (1.78) 57 0.25 (3.15) .292
CD (n ¼ 76) 8 0.23 (7.92) 20 2.86 (3.16) 48 3.68 (4.13) .023
RD (n ¼ 104) 4 1.94 (2.23) 21 0.95 (4.39) 79 2.83 (4.66) .076
BPCD (n ¼ 45) 11 3.84 (4.17) 18 6.52 (6.28) 16 9.34 (7.05) .959
BPCD¼ bipolar cell dysfunctions; CD¼ cone-dominated dystrophies; RD¼ rod-dominated dystrophies; RPE¼ retinal pigment epithelium–
related macular dystrophies; SE ¼ spherical equivalent.
P value calculated with Student t test; P < .05 was considered statistically significant.This suggests that bipolar cells may be important players in
myopia development.
Although systematic reports are lacking, occasional case
series have reported refractive errors in patients with IRD.
Mild refractive errors have been described for Stargardt and
Best disease7,9; more severe refractive errors for CSNB and
for RP caused by RPGR and RP1.6,16,23–26 Our
comprehensive analyses show that RPE-related dystrophies
such as Stargardt, Best, and pattern dystrophy indeed
mostly have mild refractive errors. Photoreceptor disorders
have more variability in refractive error but are also mildly
myopic on average; CDs have a somewhat higher frequency
of moderate myopia than RP. Our study indicates that
BPCD predominantly leads to severe refractive errors,
and notably, the direction of SE is dependent on the causal
gene.
Our study has a unique design in myopia research. We
selected patients with a known primary defect in the retina
and studied the effect on refractive error. We focused on
several affected cell types as well as on causal genes within
each cell type. Because myopia develops at childhood and
early youth, we stratified for age and found differential ef-
fects even in those with a very early onset. Our study isVOL. 182 BIPOLAR SYNAPSE AND PHOTORECEPTOthe only systematic investigation on refractive error and
IRD to date, and it includes a broad spectrum of diagnoses.
In addition, we had access to large population-based
studies, which we used as a reference population in the
evaluation of risk of refractive error. Our study has draw-
backs as well. Although our total sample size was substan-
tial, subgroup analyses were limited by small numbers.
The age ranges of the 2 reference populations differed;
however, comparison to the single populations did not
significantly alter the risk estimates (data not shown).
Lastly, our IRD patients lacked data on established risk fac-
tors for myopia such as familial occurrence of myopia and
educational level, as well as the age of onset of myopia.
A striking finding of our study was that malfunctioning
bipolar cell synapses can lead to high myopia. Bipolar cells
are known to transmit signals from photoreceptors to
amacrine and ganglion cells.27 They can be divided by
ON and OFF subtypes. ON bipolar cells depolarize,
whereas OFF bipolar cells hyperpolarize when the retina
is stimulated by light. Rod signal transmission primarily oc-
curs through ON bipolar cells, whereas cones connect with
both ON and OFF bipolar cells. BPCD are known to affect
the ON bipolar cells. Whether a dysfunctional OFF bipolar85R AS CRITICAL SITES FOR MYOPIA
FIGURE 4. Distribution of refractive errors for gene-specific inherited retinal dystrophies. Top: Box plots of the distribution of
spherical equivalent (in diopters) on y-axis per specific causal gene on x-axis. *, significantly different from the reference population
at P value< .05 (independent samples t test). Causal genes that were found in fewer than 3 patients were not included in this figure,
but their standard error measurements can be found in Table 2. Bottom: Localization of retinal dystrophy gene products in the retina.
In green: cone-specific genes. In red: rod-specific genes.synapse causes refractive errors is unknown, since gene mu-
tations in these cells are lethal and not a cause of IRD.
Therefore, this study can only make conclusions about
the role of ON bipolar cells in development of myopia.
If we take a closer look at genes causing BPCD, our study
shows that mutations in CACNA1F, NYX, and TRPM1
often coincide with high myopia, whereas mutations in
CAPB4 coincide with high hyperopia. CACNA1F is a pre-
synaptic Ca channel present in the rod; TRPM1 and NYX
are essential components of the postsynaptic glutamate re-
ceptor complex at the ON bipolar cell dendrites.25,28,29
CACNA1F and CAPB4 are both involved in the
calcium-dependent release of glutamate at the photore-
ceptor synapse, whereas the latter 2 genes are involved in
an intracellular signaling cascade converting the glutamate
receptor activation into a voltage response of the ON bipo-
lar cell.25,29 CAPB4 is a calcium binding protein located in
the presynaptic terminal of cones.25,29–31 Mutation in
CABP4 leads to photophobia rather than nyctalopia and
is considered a cone synaptic disorder.32 This suggests
that the rod-specific ON bipolar cell routing could lead
to myopia, whereas cone-specific ON bipolar cell routing
leads to hyperopia.
Genes affecting photoreceptors can cause various refrac-
tive errors. Mutations in RPGR, which is located in the
connecting cilium and is involved in microtubular trans-
port, cause high myopia, whereas mutations in USH2A,86 AMERICAN JOURNAL OFwhich is located at the apical side of the inner segment
and is involved in the maintenance of the photoreceptor,
cause only mild myopia. Mutations involved in phototrans-
duction genes do not show consistent associations with
refractive errors, although they rarely lead to emmetropia.
Thus, the critical site for myopia in photoreceptors appears
to be the transport area between the inner and outer
segment.
The currently known genes for refractive error show
some striking overlap with genes for IRD.4,33 Tophits
have been found in or near genes involved in the visual
cycle and retinoic acid metabolism, that is, common
variants in RDH5 (encoding retinol dehydrogenase 5)
and RGR (encoding the retinal G protein–coupled
receptor).4,33 Mutations in RDH5 cause a progressive
cone dystrophy34,35 and fundus albipunctatus,26,36 and
mutations in RGR are involved in retinitis
pigmentosa.37,38 Another interesting genomic locus
includes CACNA1D (encoding a voltage-sensitive cal-
cium channel),33 which shows great similarity with the
CACNA1F gene mentioned earlier. Both genes encode
an alpha subunit in the L-type calcium channel, localized
in the presynaptic ribbon terminals of photoreceptors.
Lastly,GRIA4 (encoding the ionotropic AMPA glutamate
receptor GluR4) encodes a glutamate-gated ion channel
that mediates fast synaptic excitatory neurotransmission,
is present in the retina, and is crucial forOCTOBER 2017OPHTHALMOLOGY
FIGURE 4. (continued).
VOL. 182 87BIPOLAR SYNAPSE AND PHOTORECEPTOR AS CRITICAL SITES FOR MYOPIA
emmetropization.39–42 We speculate that mutations in
these IRD genes cause retinal dystrophies, whereas
common genetic variants within these genes may be
clinically significant as myopia.
In conclusion, we showed that many genes involved in
IRD coincide with myopia. Most genes cause a relatively
mild myopia, but several genes causing BPCD and RP88 AMERICAN JOURNAL OFparticularly predispose to high myopia. We determined
critical sites for refractive error development: transport be-
tween inner and outer segment of the photoreceptor,
calcium-dependent glutamate release by photoreceptors,
and bipolar neurotransmission and routing. These retinal
sites are candidates for more in-depth investigation by
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